Cumulative anticholinergic exposure is associated with poor memory and executive function in older men

Journal of the American Geriatrics Society

Volumn 56, Issue 12, 2008, Pages 2203-2210

  Han, Ling ^a   Agostini, Joseph V ^a,b   Allore, Heather G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Anticholinergic score; Cognitive test; Cohort study; Medication use; Older men; Polypharmacy

Indexed keywords

AMITRIPTYLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FEXOFENADINE; NORTRIPTYLINE; PAROXETINE; RANITIDINE;

AGED; ARTICLE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RISK FACTOR; SHORT TERM MEMORY;

ACTIVITIES OF DAILY LIVING; AGED; CHOLINERGIC ANTAGONISTS; HUMANS; MALE; MEMORY DISORDERS; PROSPECTIVE STUDIES;

EID: 57149143738     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.02009.x     Document Type: Article

References (39)

1. Larson EB, Kukull WA, Buchner D et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 1987 107 : 169 173.
2. Bowen JD, Larson EB. Drug-induced cognitive impairment. Defining the problem and finding solutions. Drugs Aging 1993 3 : 349 357.
3. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacotherapy 1999 33 : 1147 1153.
4. Hanlon JT, Fillenbaum GG, Kuchibhatla M et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002 40 : 166 176.
5. Landi F, Russo A, Liperoti R et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007 81 : 235 241.
6. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993 3 : 335 348.
7. Tune LE, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Dis 1999 10 : 342 344.
8. Broks P, Preston GC, Traub M et al. Modeling dementia: Effects of scopolamine on memory and attention. Neuropsychologia 1988 26 : 685 700.
9. Beatty WW, Butters N, Janowsky DS. Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia. Behav Neur Biol 1986 45 : 196 211.
10. Itil T, Fink M. Anticholinergic drug-induced delirium: Experimental modification, quantitative EEG, and behavioral correlations. J Nerv Ment Dis 1966 143 : 492 507.
11. Ray PG, Meador KJ, Loring DW et al. Central anticholinergic hypersensitivity in aging. J Geriatr Psychiat Neurol 1992 5 : 72 77.
12. Colley CA, Lucas LM. Polypharmacy: The cure becomes the disease. J Gen Intern Med 1993 8 : 278 283.
13. Onder G, Landi F, Liperoti R et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005 61 : 453 459.
14. Blazer DG II, Federspiel CF, Ray WA et al. The risk of anticholinergic toxicity in the elderly: A study of prescribing practices in two populations. J Gerontol 1983 38 : 31 35.
15. Mulsant BH, Pollock BG, Kirshner M et al. Serum anticholinergic activity in a community-based sample of older adults: Relationship with cognitive performance. Arch Gen Psychiatry 2003 60 : 198 203.
16. Lechevallier-Michel N, Molimard M, Dartigues JF et al. Drugs with anticholinergic properties and cognitive performance in the elderly: Results from the Paquid Study. Br J Clin Pharmacol 2005 59 : 143 151.
17. Hilmer SN, Mager DE, Simonsick EM et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007 167 : 781 787.
18. Ancelin ML, Artero S, Portet F et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. BMJ 2006 332 : 455 459.
19. Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry 2003 11 : 458 461.
20. Agostini JV, Tinetti ME, Han L et al. Effects of statin use on muscle strength, cognition, and depressive symptoms in older adults. J Am Geriatr Soc 2007 55 : 420 425.
21. Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997 157 : 2413 2446.
22. Brandt J. The Hopkins Verbal Learning Test: Development of a new memory test with six equivalent forms. Clin Neuropsychol 1991 5 : 125 142.
23. Kuslansky G, Katz M, Verghese J et al. Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State Examination. Arch Clin Neuropsychol 2004 19 : 89 104.
24. Fillenbaum GG. Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Hillsdale, NJ : Lawrence Erlbaum Associates, Inc., 1988.
25. Han L, McCusker J, Cole M et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001 161 : 1099 1105.
26. Tune L, Carr S, Hoag E et al. Anticholinergic effects of drugs commonly prescribed for the elderly: Potential means for assessing risk of delirium. Am J Psychiatry 1992 149 : 1393 1394.
27. Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989 149 : 2414 2420.
28. Carnahan RM, Lund BC, Perry PJ et al. The relationship of an anticholinergic rating scale with serum anticholinergic activities in elderly nursing home residents. Psychopharmacol Bull 2002 36 : 14 19.
29. Carnahan RM, Lund BC, Perry PJ et al. The anticholinergic scale as a measure of drug-related anticholinergic burden: Association with serum anticholinergic activity. J Clin Pharmacol 2006 46 : 1481 1486.
30. Rudd KM, Raehl CL, Bond CA et al. Methods for assessing drug-related anticholinergic activity. [Review]. Pharmacotherapy 2005 25 : 1592 1601.
31. American Society of Hospital Pharmacists. American Hospital Formulary Service. Drug information. Bethesda, MD : American Society of Hospital Pharmacists, 1994.
32. Prince MJ. The treatment of hypertension in older people and its effect on cognitive function [Review]. Biomed Pharmacotherapy 1997 51 : 208 212.
33. Wurzelmann J, Frishman WH, Aronson M et al. Neuropsychological effects of antihypertensive drugs. Cardiol Clin 1987 5 : 689 701.
34. Foy A, O'Connell D, Henry D et al. Benzodiazepine use as a cause of cognitive impairment in elderly hospital inpatients. J Gerontol Biol Sci Med Sci 1995 50A : M99 M106.
35. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977 1 : 385 401.
36. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 383.
37. Collet JP, Boivin JF. Bias and confounding in pharmacoepidemiology. In : Strom BL, ed. Pharmacoepidemiology. New York : John Wiley & Sons, 2000, pp 765 784.
38. Littell RC, Milliken GA, Stroup WW et al. SAS System for Mixed Models. Cary, NC : SAS Institute Inc., 1996.
39. Cohen J. Applied Multiple Regression - Correlation Analysis for the Behavioral Sciences. Mahwah, NJ : Lawrence Erlbaum Associates, Inc., 2003.